Iannone Robert (CIK 1737329) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-31). Recent activity: Buy JAZZ (26,116 shares), Buy JAZZ (884 shares), Buy JAZZ (27,584 shares), Buy JAZZ (2,916 shares), Sell JAZZ (18,187 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 26,116 | $3.0M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 884 | $99,980 |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 27,584 | $3.8M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 2,916 | $399,842 |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 18,187 | $4.5M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 11,423 | $2.8M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 18,113 | $4.5M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 19,639 | $4.9M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 9,259 | $2.3M |
| 2026-08-31 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 300 | $75,828 |
| 2026-07-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 3,764 | $894,778 |
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 6,209 | $1.2M |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 14,822 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Buy | 11,699 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 4,140 | $708,602 |
| 2025-11-19 | Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | Sell | 7,159 | $1.2M |
来源：SEC Form 4 申报文件 · 截至 2026-08-31